EUCTR2012-002216-10-PL
进行中（未招募）
1 期
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 or Placebo Treatment in Protocol BA058-05-003
概览
- 阶段
- 1 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Osteoporosis in postmenopausal women
- 发起方
- Radius Health, Inc.
- 入组人数
- 1600
- 状态
- 进行中（未招募）
- 最后更新
- 9年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\.The subject was enrolled, randomized to BA058 Injection 80 µg/Placebo and completed 18\-months of blinded treatment within Study BA058\-05\-003\.
- •2\.The subject is no more than 40 days from last study medication administration.
- •3\.The subject has read, understood, and signed the written informed consent form for the Extension Study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 1000
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range 600
排除标准
- •1\.Subjects who were withdrawn from Study BA058\-05\-003 for any reason.
- •2\.Subjects who experienced a treatment\-related SAE during Study BA058\-05\-003\.
结局指标
主要结局
未指定
相似试验
进行中（未招募）
1 期
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 or Placebo Treatment in Protocol BA058-05-003Osteoporosis in postmenopausal womenMedDRA version: 18.0Level: PTClassification code 10031285Term: Osteoporosis postmenopausalSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2012-002216-10-LTRadius Health, Inc.1,600
进行中（未招募）
1 期
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 or Placebo Treatment in Protocol BA058-05-003Osteoporosis in postmenopausal womenMedDRA version: 18.1Level: PTClassification code 10031285Term: Osteoporosis postmenopausalSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2012-002216-10-CZRadius Health, Inc.1,600
进行中（未招募）
1 期
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 or Placebo Treatment in Protocol BA058-05-003EUCTR2012-002216-10-DKRadius Health, Inc.1,600
进行中（未招募）
1 期
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 or Placebo Treatment in Protocol BA058-05-003Osteoporosis in postmenopausal womenMedDRA version: 18.1Level: PTClassification code 10031285Term: Osteoporosis postmenopausalSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2012-002216-10-EERadius Health, Inc.1,600
已完成
3 期
Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With OsteoporosisPostmenopausal OsteoporosisNCT01657162Radius Health, Inc.1,139